
Walgreens is owned by Sycamore Partners through Walgreens Boots Alliance. The private equity firm completed its roughly $10 billion acquisition on August 28, 2025, taking the company private and spinning Walgreens out as a standalone business led by CEO Mike Motz. Walgreens operates about 8,000 U.S. stores and serves more than 9 million customers daily.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Walgreens | Walgreens Boots Alliance | Subsidiary |
Charles R. Walgreen opened his first drugstore in Chicago in 1901, having bought the store where he worked as a pharmacist. By 1916 he had nine stores and incorporated the Walgreen Company. The chain became famous during Prohibition for selling whiskey under prescription, a legal loophole that powered rapid expansion to more than 500 stores by 1929.
Walgreens went public in 1927 and kept expanding through the twentieth century, pioneering self-service drugstore formats, drive-through pharmacy windows in the 1990s, and computerized pharmacy networks linking all stores. It became the largest drugstore chain in the United States by store count and prescriptions filled.
In 2010, Walgreens acquired the New York City chain Duane Reade for approximately $1.1 billion, cementing its position in the country's largest metro market. In 2012, it bought a 45% stake in Alliance Boots, the European pharmacy and beauty company, and completed the full acquisition in 2014 to form Walgreens Boots Alliance.
The 2020s were difficult. Prescription reimbursement pressure, front-of-store retail decline, theft, and the costly VillageMD primary care expansion dragged results. In October 2024, the board approved a footprint optimization plan to close 1,200 to 1,300 U.S. stores by the end of fiscal 2027. In March 2025, WBA agreed to be acquired by Sycamore Partners, and the deal closed August 28, 2025.
Since going private, Walgreens has operated as an independent company under Mike Motz, focusing on store experience, pharmacy services, and cost discipline without quarterly earnings pressure.
Is Walgreens Boots Alliance publicly traded?
No. WBA was delisted from Nasdaq on August 28, 2025, when Sycamore Partners completed its acquisition. The company is now privately held and its businesses operate as standalone companies.
Who acquired Walgreens Boots Alliance?
Sycamore Partners, a New York-based private equity firm, acquired WBA in partnership with the family of former executive chairman Stefano Pessina. The deal closed August 28, 2025, paying shareholders $11.45 per share plus contingent value rights, valued at roughly $10 billion for equity and $23.7 billion including debt.
Who is the CEO of Walgreens Boots Alliance?
Following the Sycamore split, the former WBA businesses have separate leadership. Mike Motz, formerly CEO of Staples US Retail, is CEO of Walgreen Co. Former WBA CEO Tim Wentworth (appointed October 2023) remains a director.
What is Walgreens Boots Alliance's revenue?
Walgreens Boots Alliance reported FY2024 revenue of $147.7 billion (fiscal year ended August 31, 2024). The company reported a net loss of $8.8 billion, primarily due to a $5.8 billion VillageMD impairment charge and other goodwill write-downs. Adjusted EBITDA was approximately $4.1 billion.
Why is Walgreens closing stores?
Walgreens announced plans to close approximately 1,200 underperforming U.S. stores as part of a turnaround strategy. The closures reflect declining retail pharmacy margins, competition from online retailers, and the need to optimize the company's physical footprint. The closures have raised concerns about pharmacy access in underserved communities.
What is VillageMD?
VillageMD is a primary care provider in which Walgreens Boots Alliance holds a majority stake. WBA invested $5.2 billion in VillageMD in 2021 with plans to open co-located clinics inside Walgreens stores. The investment has struggled financially, resulting in a $5.8 billion impairment charge in FY2024. WBA has announced plans to reduce its stake in VillageMD.
When was Walgreens Boots Alliance founded?
Walgreens Boots Alliance was formed on December 31, 2014, through the merger of Walgreens and Alliance Boots. Walgreens was founded in 1901 by Charles R. Walgreen Sr. in Chicago. Boots was founded in 1849 by John Boot in Nottingham, England.
Walgreens has faced recurring regulatory and public scrutiny. In 2024, a federal judge ruled that Walgreens contributed to San Francisco's opioid crisis through lax dispensing controls, part of a broader wave of pharmacy opioid litigation that produced multibillion-dollar settlements across the industry. Walgreens previously agreed to pay roughly $5.7 billion over 15 years in a national opioid settlement framework.
The chain has also drawn criticism for staffing levels and pharmacist workloads, including 2023 walkouts by pharmacy staff over working conditions. Store closures under the footprint program have generated local pushback in cities losing neighborhood pharmacies. Rite Aid's collapse and CVS's parallel restructuring make pharmacy deserts an industry-level policy issue.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Walgreens Boots Alliance | USA | 1960 | Mass market | United states | All Genders | |
| Cvs Health | United States | 1938 | Mass market | United states | All Genders | |
| Amazon | USA | 2020 | Mass market | United states | All Genders | |
| Cvs Health | USA | 1963 | Mass market | United states | All Genders | |
| Mckesson | USA | 1985 | Mass market | United states | All Genders | |
| Cvs Health | United States | 1940 | Mass market | Regional | All-ages |
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain operating in Hawaii, owned by CVS Health. Approximately 70 stores serving Hawaiian communities.
Healthcare PharmaceuticalsOwned by Amazon.com Inc.
Amazon's online pharmacy service offering prescription medications and home delivery, operating as a division of Amazon.com Inc.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
Healthcare PharmaceuticalsOwned by McKesson Corporation
Independent pharmacy franchise network with over 4,500 member pharmacies across the United States, owned by McKesson Corporation and ranked highest in J.D. Power pharmacy satisfaction.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
Retail pharmacy chain serving Hispanic and Latino communities in South Florida. Owned by CVS Health since 2014. 33 stores across Miami-Dade, Broward, Tampa, and Orlando.
Market Positioning: Walgreens competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Walgreens Boots Alliance, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain operating in Hawaii, owned by CVS Health. Approximately 70 stores serving Hawaiian communities.
Longs Drugs is owned by CVS Health Corporation, a public company, a different structure than Walgreens's parent.
Healthcare PharmaceuticalsOwned by Amazon.com Inc.
Amazon's online pharmacy service offering prescription medications and home delivery, operating as a division of Amazon.com Inc.
Amazon Pharmacy is owned by Amazon.com Inc., a public company, a different structure than Walgreens's parent.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
CVS Pharmacy is owned by CVS Health Corporation, a public company, a different structure than Walgreens's parent.
Healthcare PharmaceuticalsOwned by McKesson Corporation
Independent pharmacy franchise network with over 4,500 member pharmacies across the United States, owned by McKesson Corporation and ranked highest in J.D. Power pharmacy satisfaction.
Health Mart is owned by McKesson Corporation, a public company, a different structure than Walgreens's parent.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
Retail pharmacy chain serving Hispanic and Latino communities in South Florida. Owned by CVS Health since 2014. 33 stores across Miami-Dade, Broward, Tampa, and Orlando.
Navarro Discount Pharmacies is owned by CVS Health Corporation, a public company, a different structure than Walgreens's parent.
Healthcare PharmaceuticalsOwned by CVS Health Corporation
Long-term care pharmacy services provider, formerly owned by CVS Health. Filed for Chapter 11 bankruptcy in September 2025 after $949 million False Claims Act judgment.
Omnicare is owned by CVS Health Corporation, a public company, a different structure than Walgreens's parent.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.